Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma
- PMID: 16765178
- DOI: 10.1016/j.urology.2005.12.034
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma
Abstract
Objectives: To compare the outcomes in patients who had undergone either open nephroureterectomy or conservative endoscopic surgery (ureteroscopic or percutaneous management) for upper urinary tract transitional cell carcinoma.
Methods: We performed a retrospective review of the data for patients treated surgically for upper urinary tract transitional cell carcinoma from 1990 to 2004. The data included patient sex, age at diagnosis, mode of diagnosis, smoking history, history of bladder cancer, type of surgery, complications, and tumor site, size, stage, grade, recurrence, and progression. We also evaluated the recurrence and survival rates.
Results: Data were analyzed for 97 patients. The median patient age was 68 years. Sixteen patients had a history of bladder tumor. The surgical procedure was open nephroureterectomy in 54 patients, ureteroscopy in 27, and percutaneous endoscopic ablation in 16. The tumor stage, grade, and site were independent prognostic factors for survival in a multivariate analysis (P <0.05). The 5-year disease-specific survival rate was 81.9% for low-grade tumors and 47.3% for high-grade tumors (P = 0.0001). A correlation (P = 0.002) was found between low-grade tumors and superficial tumors. In patients with low-grade tumors (n = 46), the 5-year disease-specific survival rate after nephroureterectomy, ureteroscopy, and percutaneous endoscopy was 84%, 80.7%, and 80%, respectively (P = 0.89); the corresponding 5-year tumor-free survival rates were 75.3%, 71.5%, and 72% (P = 0.78).
Conclusions: Conservative surgery can be recommended as an alternative to nephroureterectomy for low-grade or superficial upper urinary tract transitional cell carcinoma. For patients with high-grade or invasive tumors to be candidates for conservative surgery will require the development of additional prognostic factors (eg, molecular markers). These patients require long-term postoperative surveillance.
Similar articles
-
Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.Urology. 2007 Apr;69(4):656-61. doi: 10.1016/j.urology.2007.01.007. Urology. 2007. PMID: 17445646
-
Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.Urology. 2005 Aug;66(2):283-7. doi: 10.1016/j.urology.2005.02.022. Urology. 2005. PMID: 16098357
-
Endoscopic treatment of upper tract transitional cell carcinoma.Urol Oncol. 2005 Mar-Apr;23(2):114-22. doi: 10.1016/j.urolonc.2004.10.010. Urol Oncol. 2005. PMID: 15869996 Review.
-
Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.Eur Urol. 2007 Mar;51(3):709-13; discussion 714. doi: 10.1016/j.eururo.2006.07.019. Epub 2006 Jul 28. Eur Urol. 2007. PMID: 16911852
-
Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?Eur Urol. 2004 Dec;46(6):690-7. doi: 10.1016/j.eururo.2004.08.006. Eur Urol. 2004. PMID: 15548434 Review.
Cited by
-
Survival Comparison Between Endoscopic and Surgical Management for Patients With Upper Tract Urothelial Cancer: A Matched Propensity Score Analysis Using Surveillance, Epidemiology and End Results-Medicare Data.Urology. 2016 Sep;95:115-20. doi: 10.1016/j.urology.2016.05.033. Epub 2016 May 24. Urology. 2016. PMID: 27233931 Free PMC article.
-
Experts' recommendations in laser use for the treatment of upper tract urothelial carcinoma: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training Research in Urological Surgery and Technology (T.R.U.S.T.) group.World J Urol. 2023 Nov;41(11):3367-3376. doi: 10.1007/s00345-023-04632-4. Epub 2023 Oct 1. World J Urol. 2023. PMID: 37777981
-
Percutaneous nephroscopic resection of pyelocaliceal transitional cell carcinoma in solitary kidney.Urol Ann. 2014 Jan;6(1):91-3. doi: 10.4103/0974-7796.127027. Urol Ann. 2014. PMID: 24669134 Free PMC article.
-
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.World J Urol. 2017 Mar;35(3):355-365. doi: 10.1007/s00345-016-1859-6. Epub 2016 May 27. World J Urol. 2017. PMID: 27233780 Free PMC article. Review.
-
Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma.Cancers (Basel). 2023 Sep 10;15(18):4495. doi: 10.3390/cancers15184495. Cancers (Basel). 2023. PMID: 37760465 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical